RE: March 2025: Make or break4 Mar 2025 10:12
Or is there something more sinister behind BP’s absence: if successful, Avacta would deprive them from more lucrative longterm treatment sales hence they would like to see the company fail before trials have concluded. Just an idea
What we can see in the 5y sp chart is that this is the longest period of steady decline (since mid July 24)